Skip to main content
Geratherm Medical AG logo

Geratherm Medical AG — Investor Relations & Filings

Ticker · GME ISIN · DE0005495626 LEI · 391200RRY20H0XD6QC53 F Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 484 across all filing types
Latest filing 2023-03-20 Transaction in Own Shar…
Country DE Germany
Listing F GME

About Geratherm Medical AG

https://geratherm.com/

Geratherm Medical AG is a medical technology company that develops and produces a range of medical devices and solutions for both professional and home use. For the professional market, the company provides systems for pulmonary function diagnostics, including spirometry, pulmonary function tests (PFT), and cardiopulmonary stress tests (CPET). It also offers specialized equipment such as the nomag®IC advanced, an MR diagnostics incubator system for newborns. For the consumer and home care market, Geratherm offers a portfolio of healthcare diagnostic products designed to monitor vital data. This includes clinical thermometers, blood pressure monitors, and products for women's health, such as pregnancy tests and tools for natural family planning.

Recent filings

Filing Released Lang Actions
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly mentions 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' and 'Erwerb eigener Aktien – 8. Zwischenmeldung'. This content details the company's ongoing share repurchase program, including the number of shares bought back daily and the total volume. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a short announcement (3293 chars) about a transaction, the specific nature of the transaction (share repurchase) makes POS a much better fit than the general RPA or RNS fallback.
2023-03-20 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly mentions 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' and 'Erwerb eigener Aktien – 7. Zwischenmeldung'. This content details the company's ongoing share repurchase program, including the number of shares bought back daily and the total volume. This directly relates to the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a regulatory announcement (EQS-News), the specific subject matter is the share repurchase activity, making POS the most precise classification over the general RPA or RNS.
2023-03-13 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly states 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' and 'Erwerb eigener Aktien – 6. Zwischenmeldung'. This content details the company's ongoing share repurchase program, including the number of shares bought back and the average prices over a specific period (Feb 27 to Mar 03, 2023). This directly relates to the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a regulatory announcement, the specific nature of the content (share repurchase details) makes POS a more precise classification than the general RNS or RPA.
2023-03-06 German
Geratherm Medical AG: Dr. Gert Frank, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an executive (Dr. Gert Frank), his position, the nature of the transaction (Acquisition of Shares), the price, volume, and date. This content directly matches the definition for Director's Dealing.
2023-02-28 English
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly mentions 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' and 'Erwerb eigener Aktien – 5. Zwischenmeldung'. This content details the company's ongoing share repurchase program, including the number of shares bought back and the average price over a specific period (Feb 20-24, 2023). This directly relates to the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a regulatory announcement (indicated by EQS News and EU regulation references), the specific subject matter is the repurchase activity itself, making POS a more precise fit than the general RNS or RPA.
2023-02-27 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" and explicitly mentions "Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014" and "Erwerb eigener Aktien – 4. Zwischenmeldung". This content details the company's ongoing share repurchase program, including the number of shares bought back and the average price over a specific period (Feb 13 to Feb 17, 2023). This directly relates to the company buying back or selling its own shares, which corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory announcement, the specific subject matter (share repurchase) makes POS a more precise classification than the general 'RNS' or 'RPA'. The document length is short (3299 chars), but it contains the substantive data of the transaction, not just an announcement that a report is attached.
2023-02-20 German

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.